F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Develops human-based tissue products for therapeutic applications

Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ.

Beckman Coulter, Inc. manufactures and distributes biomedical testing instrument systems and general biomedical research products. It develops and markets products that simplify, automate and innovate complex biomedical testing. The firm’s systems operate in both diagnostics and life sciences laboratories on seven continents. Its products improve the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. The company was founded in 1935 by Arnold O. Beckman and is headquartered in Brea, CA.

Nanjing Biyoukang Biotechnology Co., Ltd., established on 2007-04-29, Business scope includes biotechnology,Pharmaceutical Technology,Medical Device Technology Development,technology,transfer;food sales(A license or approval is required to operate);bio-pharmacy,Research and development of biological reagents,technical consulting,Technical Services,technology transfer;R&D of biopharmaceutical intermediates,technical consulting,Technical Services,technology transfer;Chemical Products(Does not contain hazardous chemicals),Biological Reagent Sales;production of cosmetics,Sales;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts the company to operate or prohibits the import and export of).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Coloplast A/S develops, manufactures, and markets medical products. It operates through the following segments: Chronic Care, Interventional Urology and Wound & Skin Care. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Interventional Urology segment covers the sale of urological products, including disposable products. The Wound & Skin Care segment covers the sale of wound and skin care products. The company was founded by Aage Louis-Hansen and Johanne Louise-Hansen in 1954 and is headquartered in Humlebaek, Denmark.

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. engages in the manufacture, sale, research and development of household products and medical equipment. It also develops, manufactures, markets, and sells electro-medical equipment in the patient monitoring, laboratory instrument, and medical ultrasound fields. The company was founded by Hang Xu on January 25, 1991 and is headquartered in Shenzhen, China.

URC is a global company dedicated to improving people's quality of health care, social services, and education.

Litron Laboratories Ltd. is a private company headquartered in the United States. The firm provides biotechnology, cytometric and research services.

RegeneMed accelerates the development of safer, more effective drugs by providing integrated high throughput platforms incorporating engineered human tissue-based assays. Their patented, proprietary, core technologies enable in vitro growth of engineered human tissues, including liver, GI tract, bone marrow, blood-brain barrier, cardiovascular and neuronal. The first and critical application of these tissue-based in vitro model systems is to replace cell-based assays and animal testing to debottleneck ADME/Tox evaluation, the leading cause of drug failures facing the pharmaceutical industry.

Plant Genetic Systems International, part of Bayer AG, is a Dutch company that provides biological products. The firm was founded by Daniel D. Adams.

Miles is a mobile app that automatically tracks and logs mileage for business purposes. Miles users can now create and export their mileage logs without the need of manual input.

Neurotech's founders have many years of experience in the development of innovative (cochlear) implants and implantable recording/stimulation electrodes. Neurotech SA was incorporated in 1996 to design, develop, manufacture and market active implantable medical devices for the treatment of debilitating disorders by neurostimulation.\nThe Company, in the heart of Europe near Brussels, has since acquired significant expertise in applied biomedical technology.

Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium and owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceutica was purchased by New Jersey-based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer. Janssen and Ortho-McNeil Pharmaceutical have been placed in the Ortho-McNeil-Janssen group within Johnson & Johnson Company.

Universitätsklinikum Hamburg-Eppendorf operates as a university hospital. It offers basic and specialized healthcare services, and it offers medical students an opportunity to practice their profession. The hospital was founded on the 19th of May, 1889 and is located in Hamburg, Germany.

Denali Therapeutics is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, ALS and others. Denali was founded by scientists, industry experts and investors who share the vision that recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines. Denali is rigorously pursuing a science-driven approach to translational medicine and clinical development.